Source: International Congress 2016 – Systemic biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrei Malinovschi (Uppsala, Sweden), Andrei Malinovschi, Christer Janson, Ida Mogensen, Magnus Borres, Kjell Alving. Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics. Eur Respir J 2016; 48: Suppl. 60, 1007

Member's Comments

No comment yet.

Related content which might interest you: The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Serum and exhaled condensate leptin levels in asthmatic and obese children: A pilot study Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Concentration of C-reactive protein (CRP) in elderly asthmatics Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Serum periostin but not airway POSTN expression is reduced in smokers with asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Periostin in lower airway samples and serum, a novel asthma marker? Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Elevated concentrations of CXCL8 in the nasal mucosal lining fluid of COPD patients as an accessible surrogate measure of bronchial levels Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Elevated blood eosinophil level and costs for adults with persistent asthma Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Correlation between asthma control and serum levels of IL-33 in atopic asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients Source: International Congress 2014 – Asthma and COPD management Year: 2014